Drugs / ethyl hydrogen fumarate zinc salt
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03331835 Comparator | Nov 2017 → Jan 2019 | psoriasis | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ethyl hydrogen fumarate zinc salt | “Fumaderm® tablets (120 mg dimethyl fumarate, 87 mg ethyl hydrogen fumarate calcium salt, 5 mg ethyl hydrogen fumarate magnesium salt, 3 mg ethyl hydrogen fumarate zinc salt)” NCT03331835 ↗ |
| Route | Oral | “Fumaderm® tablets are administered orally up to 3 times daily in accordance with the dosing scheme in the label.” NCT03331835 ↗ |